EMHA & Allergan meeting focus

2020-01-31T12:43:18+00:0024/01/2020|Categories: Meeting, News|

Elena Ruiz de la Torre, Executive Director of EMHA attended a business meeting on 23 January with the Allergan Company. The purpose of the meeting was to share ideas and priorities to explore areas of collaboration and identify opportunities. We also took the opportunity to share the history of migraine with Allergan Marlow employees. The attendees of the meeting focus were: EMHA:   Elena Ruiz de la Torre - Executive Director. Allergan:    Maria Fantis - Marketing, Neurosciences. Gwyn Grenrock - The Allergan Foundation. Mark Marmur - International Communications & Public Relations. Katherine Sommer - Medical Affairs, Migraine. Susan Stone [...]

Migraine at work

2020-04-28T14:13:50+00:0019/01/2020|Categories: News|

European survey. Analysis of results and conclusions. The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries. Read de complete document in our Publications section

European Migraine Day of Action with MEPS in the European Parliament

2019-09-14T19:11:32+00:0012/09/2019|Categories: News|

Each year, September 12th is the International Migraine Day of Action. Today, EMHA’s President and Executive Director have been invited by MEP Esteban Gonzalez Pons and MEP Dolors Montserrat to the European Parliament to discuss about how to better help the affected ones to give light to the disease and how to improve the life of the affected ones. Migraine is a chronic disease which negatively influences patients’ lives and their ability to fully integrate within society. About 15% of the European population has to deal with this neurological disease . It means that in average, in your country, 1 [...]

New drugs, decades in the making, are providing relief for migraines.

2018-12-11T12:47:38+00:0011/12/2018|Categories: New Treatment, News|Tags: , , |

Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The next day, she still felt horrible, the beginning of what she called a “rolling tide” of near constant migraines and lower level headaches. For three years she dealt with the symptoms. Sometimes she got tunnel vision, or a visual aura, a warning that a big headache was on the way. Those felt like “someone taking a pick and jabbing it through my nose and eye,” she said. Then there was the vomiting, [...]


2018-12-05T12:31:18+00:0005/12/2018|Categories: News|Tags: , , , , , |

What Can Yoga Do for Migraine Relief? Yoga can provide more than just physical fitness. It can bring calm and peace to your mind and body, as well as help with ailments such as anxiety, depression, and pain. It isn’t clear exactly how yoga changes the body in this manner, though the parasympathetic nervous system (PNS) may play a role. During yoga, the PNS can slow your heart rate and lower your blood pressure. This allows your body to recover after a stressful event, such as a migraine. Not only is yoga a holistic approach to fighting migraines as they’re [...]

“Green light” to Lilly’s monoclonal antibody to migraine

2018-11-28T17:21:25+00:0028/11/2018|Categories: Industry, News|Tags: , , , , , , , |

Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab ( Emgality ) as a prophylactic treatment of migraine in adults suffering from at least four days of migraine per month . Galcanezumab is a humanized monoclonal antibody that binds to the peptide related to the calcite gene (CGRP, for its acronym in English) associated with episodes of migraine, blocks its function Administered with a month subcutaneous injection which can be applied to the patient with a pen or pre-filled syringe. In all three clinical trials, galcanezumab has shown significantly reducing the monthly average of migraine days and an improvement in functionality versus placebo. "Migraine is [...]

Migraine Atlas by AEMICE

2018-11-14T19:06:40+00:0014/11/2018|Categories: News|Tags: , , |

AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the "Migraine Atlas 2018" which reflects the real situation of the 4.5 million people who suffer from migraine in Spain! Unlike other studies "Migraine Atlas" includes the patients and also their families perspective about their condition, the healthcare system, effectivity of treatments, psicological aspects, limitations within their social lives, at the workplace, at home, self-medication and or fears and hopes, all these collected through questionnaire done to more than 2.500 people with migraine. Moreover, the inform shows an analysis of the scientific lecture and other [...]

We and our partners use cookies, to collect browsing data to give you the best online experience and to personalize the content, play multimedia content, interact with social networks and perform browsing analytics. If you continue browsing we understand you accept the use of such technology. For more information visit our cookies policy Find out more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.